Meeting slides
Interactive presentation

Call a Colleague with Robert M. Genta, MD

Interactive presentation

Call a Colleague with Evan Dellon, MD, MPH

Interactive presentation

A Patient’s Journey In Her Own Words

Troyce Venturella, RN, CCM, MPH
Interactive presentation

Call a Colleague with Bruce L. Zuraw, MD

Suggested Readings

EOSINOPHILIC ESOPHAGITIS

One-hour esophageal string test: a nonendoscopic minimally invasive test that accurately detects disease activity in eosinophilic esophagitis.

Ackerman SJ, et al. Am J Gastroenterol. 2019;114(10):1614-1625.

Phenotypic characterization of eosinophilic esophagitis in a large multicenter patient population from the Consortium for Food Allergy Research.

Chehade M, et al. J Allergy Clin Immunol Pract. 2018;6(5):1534-1544.e5.

Mechanisms of disease of eosinophilic esophagitis.

Davis BP, Rothenberg ME. Annu Rev Pathol. 2016;11:365-393.

A phase 3, randomized, 3-part study to investigate the efficacy and safety of dupilumab in adult and adolescent patients with eosinophilic esophagitis: results from part A.

Dellon ES. American College Gastroenterology Conference; October 26, 2020. Abstract LB3.

Diagnosis and treatment of eosinophilic esophagitis.

Gonsalves NP, Aceves SS. J Allergy Clin Immunol. 2020;145(1):1-7.

Budesonide oral suspension improves outcomes in patients with eosinophilic esophagitis: results from a phase 3 trial.

Hirano I, et al. Clin Gastroenterol Hepatol. 2022;20(3);525-534.

Functional lumen imaging probe for the management of esophageal disorders: expert review from the clinical practice updates committee of the AGA Institute.

Hirano I, et al. Clin Gastroenterol Hepatol. 2017;15(3):P325-P334.

Type 2 inflammation in eosinophilic esophagitis: from pathophysiology to therapeutic targets.

Racca F, et al. Front Physiol. 2021;12:815842.

 

HEREDITARY ANGIOEDEMA

Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States.

Banerji A, et al. Ann Allergy Asthma Immunol. 2020;124(6):600-607.

Hereditary angioedema: new finding concerning symptoms, affected organs, and course.

Bork K, et al. Am J Med. 2006;119(3):267-274.

Hereditary angioedema.

Busse PJ, Christiansen SC. N Engl J Med. 2020;382(12):1136-1148.

Long-term safety and effectiveness of berotralstat for hereditary angioedema: the open-label APeX-S study.

Farkas H, et al. Clin Transl Allergy. 2021;11(4):e12035.

Threshold-stimulated kallikrein activity distinguishes bradykinin- from histamine-mediated angioedema.

Lara-Marquez ML, et al. Clin Exp Allergy. 2018;48(11):1429-1438

sgp120 and the contact system in hereditary angioedema: a diagnostic tool in HAE with normal C1 inhibitor.

Larrauri B, et al. Mol Immunol. 2020;119:27-34.

The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression.

Lumry WR, et al. Allergy Asthma Proc. 2010;31(5):407-414.

Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks.

Riedl MA, et al. Allergy. 2020;75(11):2879-2887.

Ecallantide.

Zuraw B, et al. Nat. Rev Drug Discov. 2010;9(3):189-190.

Hereditary angioedema with normal C1 inhibitor: four types and counting.

Zuraw BL. J Allergy Clin Immunol. 2018;141(3):884-885.

Related activities
Webcast 
1.50 CME/CE

Answering the Call

Interdisciplinary Management of Eosinophilic Esophagitis and Hereditary Angioedema

Faculty: Seema Aceves, MD, PhD; Sandra Christiansen, MD; Joshua B. Wechsler, MD, MS
Release: 05/27/2022
Expiration: 05/27/2023